Cornell-linked dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.
Embark Veterinary, a US-based canine DNA test provider co-founded by Cornell University faculty, has raised $75m in a series B round led by telecoms and internet group SoftBank’s Vision Fund 2
Investment and financial services group Fidelity’s F-Prime Capital subsidiary also participated in the round, as did SV Angel, Slow Ventures, Freestyle Capital and Third Kind Venture Capital. It valued the company at $700m post-money, it told TechCrunch.
Embark is the creator of a DNA test capable of…
